Ryan Halsted
Stock Analyst at RBC Capital
(0.23)
# 4,436
Out of 5,122 analysts
6
Total ratings
25%
Success rate
-14.32%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $47 | $44.97 | +4.51% | 1 | Jan 12, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $22.01 | +40.88% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $22.12 | +4.00% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $173.18 | - | 3 | Apr 28, 2017 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $44.97
Upside: +4.51%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $22.01
Upside: +40.88%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $22.12
Upside: +4.00%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $173.18
Upside: -